These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3197595)

  • 41. [Propafenon and lidoflazine in chronic atrial fibrillation and flutter (author's transl)].
    Beck OA; Lehmann HU; Hochrein H
    Dtsch Med Wochenschr; 1978 Jun; 103(26):1068-72. PubMed ID: 668524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Results of treatment of a coronary pain syndrome with lidoflazine].
    Dvorák I; Zemánková J; Soják K
    Vnitr Lek; 1973 Oct; 19(10):943-8. PubMed ID: 4586010
    [No Abstract]   [Full Text] [Related]  

  • 43. Beneficial effect of mioflazine in limiting myocardial infarct size in the anesthetized dog.
    Vandeplassche G; Hermans C; Borgers M; Xhonneux R; Flameng W
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):167-70. PubMed ID: 6729248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Reperfusion damages to the heart in acute transitory coronary failure and their prevention with myophedrin].
    Vasilevskaia TA; Litvitskiĭ PF
    Biull Eksp Biol Med; 1985 Jul; 100(7):97-100. PubMed ID: 4016248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A new drug for the therapy of angina pectoris and coronary insufficiency: Lidoflazine (R 7904)].
    Dziuba K
    Med Welt; 1967 Apr; 14():894-9. PubMed ID: 5585086
    [No Abstract]   [Full Text] [Related]  

  • 46. [The significance of lidoflazine in the therapy of atrial fibrillation and flutter].
    Hůla J; Pelechová J; Fikrle A
    Cas Lek Cesk; 1984 Jun; 123(25):764-6. PubMed ID: 6467324
    [No Abstract]   [Full Text] [Related]  

  • 47. [Comparison of lidoflazine and quinidine in the conversion to sinusal rhythm in atrial fibrillation of recent onset].
    Masini M; Ieri A; Lorenzoni R; Bartoli P; Lencioni G; Zipoli A; Masini G
    G Ital Cardiol; 1990 Mar; 20(3):202-6. PubMed ID: 2344897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Physio-pharmacology of coronary insufficiency. II].
    Campese VM; Marino A
    Clin Ter; 1974 Jun; 69(5):399-429. PubMed ID: 4849400
    [No Abstract]   [Full Text] [Related]  

  • 49. [Antiarrhythmic properties of lidoflazine in the therapy of auricular fibrillation and flutter (clinical studies of 26 patients)].
    Lehmann HU; Hochrein H
    Z Kardiol; 1975 Aug; 64(8):741-8. PubMed ID: 1099831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of intravenous lidoflazine on whole blood-induced basilar artery contraction. An in vivo study.
    Rosenwasser RH; Tuma RF; Buchheit WA; McDowell A
    Surg Neurol; 1987 Jun; 27(6):533-6. PubMed ID: 3576428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atrial fibrillation and hyperthyroidism: a new look at their relationship and therapy with lidoflazine.
    Bruyneel K; Verhaegen H; De Vil C
    Postgrad Med J; 1975 Jan; 51(591):4-9. PubMed ID: 1161678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Collateral coronary blood circulation and its role in the mechanism of the anti-ischemic (antianginal) action of pharmacologic preparations].
    Chichkanov GG; Tsorin IB
    Farmakol Toksikol; 1989; 52(2):15-24. PubMed ID: 2663540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The ischemic heart--causes, effects and therapy].
    Tillmanns H
    Klin Anasthesiol Intensivther; 1995; 47():206-20. PubMed ID: 7715175
    [No Abstract]   [Full Text] [Related]  

  • 54. [The activity of mitochondrial enzymes in the myocardium in chronic coronary failure during the administration of antianginal agents].
    Voronkov GS; Evstratova IN
    Eksp Klin Farmakol; 1992; 55(6):17-9. PubMed ID: 1305865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Calcium-antagonists in ischemic heart disease.
    Schaefer J
    Arch Inst Cardiol Mex; 1980; 50(3):289-93. PubMed ID: 7425746
    [No Abstract]   [Full Text] [Related]  

  • 56. A double-blind placebo-controlled cross-over study with lidoflazine (Clinium) in post-infarction patients.
    Meilink-Hoedemaker LJ; Pool J; Muste-Heijns MM
    Acta Med Scand; 1976; 199(1-2):17-23. PubMed ID: 766572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The use of lidoflazin (Clinium) as an anti-arrhythmia agent].
    Vilmos N; Ferenc P
    Orv Hetil; 1976 Aug; 117(32):1935-7. PubMed ID: 958696
    [No Abstract]   [Full Text] [Related]  

  • 58. The ultrastructure of human livers after prolonged lidoflazine therapy.
    Verheyen A; Borgers M; Blaton H; Sowa H
    Toxicol Appl Pharmacol; 1975 Nov; 34(2):224-32. PubMed ID: 1209621
    [No Abstract]   [Full Text] [Related]  

  • 59. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A quantitative morphological assessment of the effect of lidoflazine and deferoxamine therapy on global brain ischaemia.
    Kumar K; White BC; Krause GS; Indrieri RJ; Evans AT; Hoehner TJ; Garritano AM; Koestner A
    Neurol Res; 1988 Sep; 10(3):136-40. PubMed ID: 2905775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.